Edi Levi
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
- Oncology 34
- Cancer Cells and Metastasis 9
- PARP inhibition in cancer therapy 6
- Pancreatic and Hepatic Oncology Research 6
-
- Blood properties and coagulation 6
- Co-authors
- Adhip P.N. Majumdar (24 shared papers)Marshall E. Kadin (12 shared papers)Fazlul H. Sarkar (7 shared papers)Yingjie Yu (13 shared papers)Volkan N. Adsay (8 shared papers)Olca Baştürk (5 shared papers)David S. Klimstra (2 shared papers)O. Dereure (3 shared papers)
- Journals
- PLoS ONE (5 papers)Oncotarget (3 papers)Journal of Biological Chemistry (3 papers)Biochemical and Biophysical Research Communications (3 papers)Endoscopy (3 papers)
- Partner nations
- United StatesTürkiyeSaudi Arabia
In The Last Decade
Edi Levi
105 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 114
- Oncology 1.0k
- Dermatology 353
- Cancer Research 476
- Molecular Medicine 167
- Pathology and Forensic Medicine 416
Countries citing papers authored by Edi Levi
This map shows the geographic impact of Edi Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edi Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edi Levi more than expected).
Fields of papers citing papers by Edi Levi
This network shows the impact of papers produced by Edi Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edi Levi. The network helps show where Edi Levi may publish in the future.
Co-authors
The 25 scholars most cited alongside Edi Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 381 | |
| 2 | 2009 | 174 | |
| 3 | 2015 | 142 | |
| 4 | 2012 | 138 | |
| 5 | 2006 | 124 | |
| 6 | 2000 | 113 | |
| 7 | 2004 | 110 | |
| 8 | 1999 | 108 | |
| 9 | 2014 | 105 | |
| 10 | 2008 | 74 | |
| 11 | 2002 | 74 | |
| 12 | 2005 | 71 | |
| 13 | 2006 | 62 | |
| 14 | 2008 | 52 | |
| 15 | 2006 | 49 | |
| 16 | 2018 | 49 | |
| 17 | 1999 | 49 | |
| 18 | 2015 | 44 | |
| 19 | 2002 | 43 | |
| 20 | 2011 | 42 |
About Edi Levi
Edi Levi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Dermatology and Molecular Biology, having authored 108 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Cutaneous lymphoproliferative disorders research (8 papers), Cell death mechanisms and regulation (7 papers), Pancreatic function and diabetes (6 papers), PARP inhibition in cancer therapy (6 papers), Blood properties and coagulation (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Oncology (1.0k citations), Dermatology (353 citations), Cancer Research (476 citations), Molecular Medicine (167 citations) and Pathology and Forensic Medicine (416 citations). Edi Levi has collaborated with scholars based in United States, Türkiye and Saudi Arabia. Frequent co-authors include Adhip P.N. Majumdar, Marshall E. Kadin, Fazlul H. Sarkar, Yingjie Yu, Volkan N. Adsay, Olca Baştürk, David S. Klimstra, O. Dereure, Jeanette D. Cheng and Lulu Farhana. Their work appears in journals such as PLoS ONE, Oncotarget, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.